Summa Equity acquires Axion BioSystems

Summa Equity has acquired Axion BioSystems, a provider of MEA and impedance technology for single-cell analysis.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this